Novel role of p66shc in ROS-dependent VEGF signaling and angiogenesis in endothelial cells

Jin Oshikawa, Seok Jo Kim, Eiji Furuta, Cristiana Caliceti, Gin Fu Chen, Ronald D. McKinney, Frank Kuhr, Irena Levitan, Tohru Fukai, Masuko Ushio-Fukai

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

A longevity adaptor protein, is demonstrated as a key regulator of reactive oxygen species (ROS) metabolism involved in aging and cardiovascular diseases. Vascular endothelial growth factor (VEGF) stimulates endothe-lial cell (EC) migration and proliferation primarily through the VEGF receptor-2 (VEGFR2). We have shown that ROS derived from Rac1-dependent NADPH oxidase are involved in VEGFR2 autophosphor-ylation and angiogenic-related responses in ECs. However, a role of p66Shc in VEGF signaling and physiological responses in ECs is unknown. Here we show that VEGF promotes p66Shc phosphoryla-tion at Ser36 through the JNK/ERK or PKC pathway as well as Rac1 binding to a nonphosphorylated form of p66Shc in ECs. Depletion of endogenous p66Shc with short interfering RNA inhibits VEGF-induced Rac1 activity and ROS production. Fractionation of caveolin-enriched lipid raft demonstrates that p66Shc plays a critical role in VEGFR2 phosphorylation in caveolae/lipid rafts as well as downstream p38MAP kinase activation. This in turn stimulates VEGF-induced EC migration, proliferation, and capillary-like tube formation. These studies uncover a novel role of p66Shc as a positive regulator for ROS-dependent VEGFR2 signaling linked to angiogen-esis in ECs and suggest p66Shc as a potential therapeutic target for various angiogenesis-dependent diseases.

Original languageEnglish (US)
Pages (from-to)H724-H732
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume302
Issue number3
DOIs
StatePublished - Feb 1 2012

Fingerprint

Vascular Endothelial Growth Factor A
Reactive Oxygen Species
Endothelial Cells
Vascular Endothelial Growth Factor Receptor
Cell Movement
Cell Proliferation
Caveolins
Lipids
Caveolae
Vascular Endothelial Growth Factor Receptor-2
NADPH Oxidase
Small Interfering RNA
Cardiovascular Diseases
Phosphotransferases
Phosphorylation
Proteins
Therapeutics

Keywords

  • Reactive oxygen species
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Novel role of p66shc in ROS-dependent VEGF signaling and angiogenesis in endothelial cells. / Oshikawa, Jin; Kim, Seok Jo; Furuta, Eiji; Caliceti, Cristiana; Chen, Gin Fu; McKinney, Ronald D.; Kuhr, Frank; Levitan, Irena; Fukai, Tohru; Ushio-Fukai, Masuko.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 302, No. 3, 01.02.2012, p. H724-H732.

Research output: Contribution to journalArticle

Oshikawa, Jin ; Kim, Seok Jo ; Furuta, Eiji ; Caliceti, Cristiana ; Chen, Gin Fu ; McKinney, Ronald D. ; Kuhr, Frank ; Levitan, Irena ; Fukai, Tohru ; Ushio-Fukai, Masuko. / Novel role of p66shc in ROS-dependent VEGF signaling and angiogenesis in endothelial cells. In: American Journal of Physiology - Heart and Circulatory Physiology. 2012 ; Vol. 302, No. 3. pp. H724-H732.
@article{aaaf65f1e0dc41f1b8f0903a12f45bd2,
title = "Novel role of p66shc in ROS-dependent VEGF signaling and angiogenesis in endothelial cells",
abstract = "A longevity adaptor protein, is demonstrated as a key regulator of reactive oxygen species (ROS) metabolism involved in aging and cardiovascular diseases. Vascular endothelial growth factor (VEGF) stimulates endothe-lial cell (EC) migration and proliferation primarily through the VEGF receptor-2 (VEGFR2). We have shown that ROS derived from Rac1-dependent NADPH oxidase are involved in VEGFR2 autophosphor-ylation and angiogenic-related responses in ECs. However, a role of p66Shc in VEGF signaling and physiological responses in ECs is unknown. Here we show that VEGF promotes p66Shc phosphoryla-tion at Ser36 through the JNK/ERK or PKC pathway as well as Rac1 binding to a nonphosphorylated form of p66Shc in ECs. Depletion of endogenous p66Shc with short interfering RNA inhibits VEGF-induced Rac1 activity and ROS production. Fractionation of caveolin-enriched lipid raft demonstrates that p66Shc plays a critical role in VEGFR2 phosphorylation in caveolae/lipid rafts as well as downstream p38MAP kinase activation. This in turn stimulates VEGF-induced EC migration, proliferation, and capillary-like tube formation. These studies uncover a novel role of p66Shc as a positive regulator for ROS-dependent VEGFR2 signaling linked to angiogen-esis in ECs and suggest p66Shc as a potential therapeutic target for various angiogenesis-dependent diseases.",
keywords = "Reactive oxygen species, Vascular endothelial growth factor",
author = "Jin Oshikawa and Kim, {Seok Jo} and Eiji Furuta and Cristiana Caliceti and Chen, {Gin Fu} and McKinney, {Ronald D.} and Frank Kuhr and Irena Levitan and Tohru Fukai and Masuko Ushio-Fukai",
year = "2012",
month = "2",
day = "1",
doi = "10.1152/ajpheart.00739.2011",
language = "English (US)",
volume = "302",
pages = "H724--H732",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Novel role of p66shc in ROS-dependent VEGF signaling and angiogenesis in endothelial cells

AU - Oshikawa, Jin

AU - Kim, Seok Jo

AU - Furuta, Eiji

AU - Caliceti, Cristiana

AU - Chen, Gin Fu

AU - McKinney, Ronald D.

AU - Kuhr, Frank

AU - Levitan, Irena

AU - Fukai, Tohru

AU - Ushio-Fukai, Masuko

PY - 2012/2/1

Y1 - 2012/2/1

N2 - A longevity adaptor protein, is demonstrated as a key regulator of reactive oxygen species (ROS) metabolism involved in aging and cardiovascular diseases. Vascular endothelial growth factor (VEGF) stimulates endothe-lial cell (EC) migration and proliferation primarily through the VEGF receptor-2 (VEGFR2). We have shown that ROS derived from Rac1-dependent NADPH oxidase are involved in VEGFR2 autophosphor-ylation and angiogenic-related responses in ECs. However, a role of p66Shc in VEGF signaling and physiological responses in ECs is unknown. Here we show that VEGF promotes p66Shc phosphoryla-tion at Ser36 through the JNK/ERK or PKC pathway as well as Rac1 binding to a nonphosphorylated form of p66Shc in ECs. Depletion of endogenous p66Shc with short interfering RNA inhibits VEGF-induced Rac1 activity and ROS production. Fractionation of caveolin-enriched lipid raft demonstrates that p66Shc plays a critical role in VEGFR2 phosphorylation in caveolae/lipid rafts as well as downstream p38MAP kinase activation. This in turn stimulates VEGF-induced EC migration, proliferation, and capillary-like tube formation. These studies uncover a novel role of p66Shc as a positive regulator for ROS-dependent VEGFR2 signaling linked to angiogen-esis in ECs and suggest p66Shc as a potential therapeutic target for various angiogenesis-dependent diseases.

AB - A longevity adaptor protein, is demonstrated as a key regulator of reactive oxygen species (ROS) metabolism involved in aging and cardiovascular diseases. Vascular endothelial growth factor (VEGF) stimulates endothe-lial cell (EC) migration and proliferation primarily through the VEGF receptor-2 (VEGFR2). We have shown that ROS derived from Rac1-dependent NADPH oxidase are involved in VEGFR2 autophosphor-ylation and angiogenic-related responses in ECs. However, a role of p66Shc in VEGF signaling and physiological responses in ECs is unknown. Here we show that VEGF promotes p66Shc phosphoryla-tion at Ser36 through the JNK/ERK or PKC pathway as well as Rac1 binding to a nonphosphorylated form of p66Shc in ECs. Depletion of endogenous p66Shc with short interfering RNA inhibits VEGF-induced Rac1 activity and ROS production. Fractionation of caveolin-enriched lipid raft demonstrates that p66Shc plays a critical role in VEGFR2 phosphorylation in caveolae/lipid rafts as well as downstream p38MAP kinase activation. This in turn stimulates VEGF-induced EC migration, proliferation, and capillary-like tube formation. These studies uncover a novel role of p66Shc as a positive regulator for ROS-dependent VEGFR2 signaling linked to angiogen-esis in ECs and suggest p66Shc as a potential therapeutic target for various angiogenesis-dependent diseases.

KW - Reactive oxygen species

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=84863063969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863063969&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00739.2011

DO - 10.1152/ajpheart.00739.2011

M3 - Article

C2 - 22101521

AN - SCOPUS:84863063969

VL - 302

SP - H724-H732

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 3

ER -